Blog
RSS FeedPosted by Michael Wonder on 20 Sep 2025
Cost barrier emerges for breakthrough Alzheimer’s drug in Australia
19 September 2025 - The first new Alzheimer’s drug approved for use in Australia in 25 years, ticked off by ...
Posted by Michael Wonder on 19 Sep 2025
Biocon Biologics' Yesafili (aflibercept) now publicly funded in Ontario, Canada for the advanced treatment of patients with retinal diseases
18 September 2025 - -- Biocon Biologics is pleased to announce that Yesafili (aflibercept), a biosimilar to Eylea (aflibercept) injection, ...
Posted by Michael Wonder on 17 Sep 2025
PHARMAC proposes funding a new brand of ADHD medicine
17 September 2025 - PHARMAC is seeking feedback on a proposal to fund a new brand of methylphenidate to help ...
Posted by Michael Wonder on 17 Sep 2025
Hundreds of people set to benefit after life-extending lung cancer treatment given green light
16 September 2025 - Targeted immunotherapy found to significantly increase overall survival rates for people with an aggressive form of lung ...
Posted by Michael Wonder on 16 Sep 2025
AbbVie's Vraylar (cariprazine) now publicly reimbursed in Alberta
15 September 2025 - AbbVie announced today that Alberta has listed Vraylar (cariprazine) on its Health Drug Formulary. ...
Posted by Michael Wonder on 11 Sep 2025
Methods used in early value assessments for NICE: a scoping review
8 September 2025 - NICE in England introduced early value assessments as an evidence-based method of accelerating access to promising ...
Posted by Michael Wonder on 10 Sep 2025
Enhanced access to generalised myasthenia gravis treatments: UCB Canada secures pCPA agreements for Zilbrysq and Rystiggo
9 September 2025 - Important milestone brings eligible Canadians living with generalised myasthenia gravis one step closer to accessing innovative ...
Posted by Michael Wonder on 08 Sep 2025
SMC - September 2025 decisions
8 September 2025 - The SMC has today published advice on two medicines. ...
Posted by Michael Wonder on 05 Sep 2025
DoH publishes agenda for November 2025 PBAC meeting (version 3)
5 September 2025 - The DoH has published a revised agenda for the November 2025 PBAC meeting. ...
Posted by Michael Wonder on 05 Sep 2025
Ulcerative colitis: comparative study provides important insights
2 September 2025 - The data show no additional benefit of guselkumab compared to golimumab. ...
Posted by Michael Wonder on 03 Sep 2025
'More than my rent': NSW woman's $1000 a month fight for relief
3 September 2025 - Six years ago, Raphaella Kathryn Crosby could barely get out of bed. ...
Posted by Michael Wonder on 02 Sep 2025
DoH publishes revised agenda for September 2025 PBAC meeting (version 2)
2 September 2025 - The agenda for the September 2025 PBAC meeting has now been updated. ...
Posted by Michael Wonder on 02 Sep 2025
Cost of PBS scripts to be dropped to $25 from January 1 2026
2 September 2025 - Prescriptions listed on the PBS will be cut from $31.60 to $25 from January 1, 2026, ...
Posted by Michael Wonder on 01 Sep 2025
Care for people with rare and less common cancers ‘delayed and fragmented’, new report reveals
1 September 2025 - A national survey of nearly 2,500 people affected by cancer has found those with a rare ...
Posted by Michael Wonder on 01 Sep 2025
More cheaper medicines now available for Australians
1 September 2025 - From today, Australians with paediatric psoriasis, fibrodysplasia, asthma, cystic fibrosis and blood cancer now have access ...